Brief: Panbela Starts Phase II Trial Of Cpp-1X-T For Recent Onset Type I Diabetes, In Collaboration With Indiana University School Of Medicine And Jdrf
11/01/2023 14:09
Jan 11 (Reuters) - Panbela Therapeutics Inc PBLA.O :
* PANBELA STARTS PHASE II TRIAL OF CPP-1X-T FOR RECENT ONSET
TYPE
I DIABETES, IN COLLABORATION WITH INDIANA UNIVERSITY SCHOOL OF
MEDICINE AND JDRF
* PANBELA STARTS PHASE II TRIAL OF CPP-1X-T FOR RECENT ONSET
TYPE
I DIABETES, IN COLLABORATION WITH INDIANA UNIVERSITY SCHOOL OF
MEDICINE AND JDRF
Source text for Eikon: ID:nGNX3Bg9Ts
Further company coverage: PBLA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Panbela Therapeutics
See all newsBrief: Panbela Therapeutics Announces Third Independent Safety Review Of Phase 3 Aspire Clinical Trial DSMB Recommended Continuation With No Trial Modification
Brief: Nasdaq Notifies Panbela Therapeutics Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard
Brief: Panbela Announces Pricing of Approximately $9 Mln Public Offering
U.S. STOCKS ON THE MOVE-Fisker, Best Buy, NuStar Energy
Brief: Panbela Therapeutics Announces Exercise Of Warrants And Issuance Of New Warrants